Showing 2351-2360 of 3039 results for "".
- Nanoscope Therapeutics Wins 'Best of Show' Award at AAO Eyecelerator 2023https://modernod.com/news/nanoscope-therapeutics-wins-best-of-show-award-at-aao-eyecelerator-2023/2481955/Nanoscope Therapeutics was awarded the 'Best of Show in Retina' award at this year's American Academy of Ophthalmology (AAO) Eyecelerator conference held in San Francisco on Thursday, November 2, 2023. During the conference, Samuel Barone, MD, Nanoscope's chief
- ASCRS Names Abigail Markward New Executive Directorhttps://modernod.com/news/ascrs-names-abigail-markward-new-executive-director/2481952/The American Society of Cataract and Refractive Surgery (ASCRS) has named Abigail Markward as the new Executive Director of the ASCRS Foundation. Ms. Markward has more than two decades of expertise in strategic communications, marketing, publishing, and nonprofit roles. Most recent
- Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websiteshttps://modernod.com/news/ace-vision-group-adds-four-ophthalmologists-to-medical-advisory-board-launches-new-corporate-and-medical-affairs-websites/2481941/Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for e
- Pantheon Vision Raises $2.5 Million in Seed Funding to Launch Development of Bioengineered Corneal Implanthttps://modernod.com/news/pantheon-vision-raises-25-million-in-seed-funding-to-launch-development-of-bioengineered-corneal-implant/2481936/Pantheon Vision has announced $2.5 million in seed financing from Baltimore-based KeraLink International (KLI), a non-profit organization singularly focused on eradicating corneal blindness with an emphasis on low- and middle-income countries. The funding will be us
- FDA Grants Breakthrough Device Status to Toku’s Patented Cardiovascular Risk AI (CLAiR) Platformhttps://modernod.com/news/fda-grants-breakthrough-device-status-to-tokus-patented-cardiovascular-risk-ai-clair-platform/2481934/Toku announced that the FDA has granted Breakthrough Device designation to its patented CLAiR technology. According to Toku, the CLAiR platform, if cleared by the FDA, will be the first medical device in the US market that can provide affordable, point-of-care and non-invasive
- ADA and Genentech Launch Campaign to Raise Awareness and Address Inequity in Diabetes-Related Eye Diseasehttps://modernod.com/news/ada-and-genentech-launch-campaign-to-raise-awareness-and-address-inequity-in-diabetes-related-eye-disease/2481933/The American Diabetes Association (ADA) and Genentech, anchor partner of the ADA’s 'Health Equity Now' program, launched the 'Eye Pledge to Fight Diabetes.' This program encourages people with diabetes and their loved ones to get an annual eye exam, which have
- Centricity Vision Announces Commercial Launch of ZEPTOLink IOL Positioning System at AAOhttps://modernod.com/news/centricity-vision-announces-commercial-launch-of-zeptolink-iol-positioning-system-at-aao/2481931/Centricity Vision announced the commercial launch of its ZEPTOLink IOL Positioning System at the American Academy of Ophthalmology (AAO) annual meeting, November 3-6 in San Francisco. The new platform integrates the ZEPTO precision pulse capsulotomy technology with any phaco s
- Vision Innovation Partners Names Chris Moore as CEOhttps://modernod.com/news/vision-innovation-partners-names-chris-moore-as-ceo/2481914/Vision Innovation Partners (VIP), a Mid-Atlantic eye care platform with nearly 70 locations, announced the promotion of existing board member and current President, Chris Moore, to Chief Executive Officer. Former CEO and founder Mike Dunn is now serving as Executive Vice President of Business Dev
- Roche Stops Clinical Development of Oral Drug Candidate for Diabetic Retinopathyhttps://modernod.com/news/roche-stops-clinical-development-of-oral-drug-candidate-for-diabetic-retinopathy/2481902/Roche has decided to stop development of vicasinabin, an oral drug cadidate being evaluated for non-proliferative diabetic retinopathy, after completing phase 2 trials, according to a FiercePharma
- Prevent Blindness to Host “World Sight Day” Congressional Briefing and Free Vision Screening on Capitol Hillhttps://modernod.com/news/prevent-blindness-to-host-world-sight-day-congressional-briefing-and-free-vision-screening-on-capitol-hill/2481872/Nonprofit Prevent Blindness will be hosting a Congressional Briefing and free vision screening on October 12 from 10 am to 2 pm ET. The event, with support from the Prevention of Blindness Society of Metropolitan Washington, is part of this year’s